SentreHeart – BIBA Medtech Insights

AtriCure agrees to buy LARIAT developer SentreHEART

LARIAT AtriCure has entered into a definitive agreement to acquire SentreHEART, which developed the LARIAT device for left atrial appendage closure in patients with atrial fibrillation. A press release reports that the transaction consideration consists of an upfront payment of approximately US$40 million in cash and AtriCure common stock, plus additional contingent [...]

AtriCure to buy percutaneous LAA device company SentreHEART

AtriCure–developer of Isolator synergy ablation system for persistent atrial fibrillation—has entered into a definitive agreement to acquire SentreHEART, a privately held developer of percutaneous left atrial appendage (LAA) management solutions (including the LARIAT device). Under the terms of the agreement to acquire SentreHEART, the transaction consideration consists of an upfront payment of approximately $40 [...]